Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yunnan Baiyao Ointment + New Rubber Patch is a topical Traditional Chinese Medicine (TCM) combination product currently in Phase 2 clinical development by Yunnan Baiyao Group. The product integrates a TCM ointment with a rubber-based adhesive patch for transdermal delivery, specifically targeting joint pain associated with rheumatoid arthritis and various orthopedic conditions. The formulation is derived from the proprietary Yunnan Baiyao herbal formula, which includes components such as *Panax notoginseng* (Sanqi). These ingredients are traditionally recognized for their anti-inflammatory, analgesic, and blood-circulation-promoting properties. As a multi-component TCM product, it likely acts through multiple biological pathways rather than a single molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yunnan Baiyao Ointment + New Rubber Patch.